Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St PETER HIV: Varenicline vs Cytisine vs NRT for Alcohol and Smoking in HIV
NCT02797587Phase 3Completed
- Sponsor
- Boston Medical Center
- Start
- Jul 2017
- Primary completion
- Apr 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline + nicotine patch, cytisinicline in alcohol use disorder (AUD), Tobacco Use Disorder (TUD), sponsored by Boston Medical Center. Started Jul 2017; status: completed.
02
Drugs
varenicline + nicotine patchcytisinicline
03
Conditions
alcohol use disorder (AUD)Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02797587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02797587.